Join the Abrysvo group to help and get support from people like you.
Abrysvo News (Page 2)
U.S. FDA Approves Abrysvo, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational Age
NEW YORK--(BUSINESS WIRE) August 21, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Abrysvo™ (Respiratory Syncytial Virus Vaccine), the c...
Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk
MONDAY, Aug. 21, 2023 – Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals. Prior vaccination with the shingles...
Most Infants Hospitalized With RSV Were Otherwise Healthy, Study Finds
TUESDAY, Aug. 15, 2023 – As experts begin preparing for another season of viruses, they now know that even healthy infants with no underlying health issues are at risk for severe respiratory...
Education on Approval Process May Increase Acceptance of New RSV Vaccines
MONDAY, Aug. 14, 2023 – People are more likely to recommend that a pregnant family member or friend get vaccinated to protect the infant from respiratory syncytial virus (RSV) if they are shown...
FDA Approves Abrysvo (respiratory syncytial virus vaccine) for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults
NEW YORK--(BUSINESS WIRE) May 31, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Abrysvo™ (Respiratory Syncytial Virus Vaccine), the c...
Ask a question
To post your own question to this support group, sign in or create an account.